Ruben Hernaez
Overview
Explore the profile of Ruben Hernaez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
3399
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gurley T, Hernaez R, Cerda V, Thomas T, Narasimman M, Mittal S, et al.
EClinicalMedicine
. 2025 Mar;
81:103113.
PMID: 40040860
Background: Patients with cirrhosis are at high risk for hepatocellular carcinoma (HCC), but few undergo guideline-recommended semi-annual screening. Randomized clinical trials (RCTs) demonstrate that mailed outreach can increase screening versus...
2.
Lee T, Cholankeril G, Kim D, Hernaez R, Newman K
Gastroenterology
. 2025 Feb;
PMID: 39914780
No abstract available.
3.
Pose E, Jimenez C, Zaccherini G, Campion D, Piano S, Uschner F, et al.
JAMA
. 2025 Feb;
333(10):864-874.
PMID: 39908052
Importance: There are no useful treatments to prevent the development of severe complications of liver cirrhosis. Simvastatin and rifaximin have shown beneficial effects in liver cirrhosis. Objective: To assess whether...
4.
Cholankeril G, Taylor T, Kramer J, Liu Y, Hernaez R, Patidar K, et al.
Am J Gastroenterol
. 2025 Feb;
PMID: 39907257
Introduction: Current knowledge of cirrhosis progression is derived from outdated data. We examined the progression patterns of cirrhosis in a contemporary cohort. Methods: We conducted a retrospective cohort study of...
5.
Shi M, Pungwe P, Comer L, Balakrishnan M, Lee T, Cholankeril G, et al.
Hepatology
. 2025 Jan;
PMID: 39874480
Background: Severe alcohol-associated hepatitis (AH) is rising in incidence with a high mortality burden. While corticosteroids are recommended for eligible patients with severe AH, no guidance exists for the timing...
6.
Ali F, Nguyen M, Hernaez R, Huang D, Wilder J, Piscoya A, et al.
Gastroenterology
. 2025 Jan;
168(2):267-284.
PMID: 39863345
Background & Aims: Hepatitis B reactivation (HBVr) can occur due to a variety of immune-modulating exposures, including multiple drug classes and disease states. Antiviral prophylaxis can be effective in mitigating...
7.
Cholankeril G, Thrift A, Khaderi S, Kanwal F, El-Serag H, Duong H, et al.
Clin Gastroenterol Hepatol
. 2024 Dec;
PMID: 39694208
No abstract available.
8.
Yakovchenko V, Chang M, Hernaez R, Awad J, Anwar J, Nobbe A, et al.
Dig Dis Sci
. 2024 Dec;
70(2):552-565.
PMID: 39661277
Background: As the largest US provider of cirrhosis care, the Veterans Health Administration (VA) is the ideal setting to assess patient-, clinician-, and site-level barriers to transplant evaluation. Aims: To...
9.
10.
Singal A, Daher D, Narasimman M, Mhi S, Yekkaluri S, Liu Y, et al.
J Natl Cancer Inst
. 2024 Sep;
117(2):262-269.
PMID: 39288308
Background: The value of hepatocellular carcinoma screening is defined by the balance of benefits from early tumor detection vs harms because of false-positive results. We evaluated the value of a...